| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1044349850 |
| P356 | DOI | 10.1186/S13054-014-0523-Z |
| P8608 | Fatcat ID | release_updr3og6jbbtvfwiratpafzfzm |
| P932 | PMC publication ID | 4331447 |
| P698 | PubMed publication ID | 25673176 |
| P5875 | ResearchGate publication ID | 272188849 |
| P2093 | author name string | Daniel C Grinnan | |
| Hadi Chohan | |||
| Katie M Muzevich | |||
| P2860 | cites work | Inhaled prostacyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: a pharmacodynamic study. | Q51556270 |
| Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. | Q52422731 | ||
| Acute Renal Failure in Critically Ill Patients A Multinational, Multicenter Study | Q61363260 | ||
| Stability of an extemporaneously prepared tadalafil suspension | Q83732038 | ||
| Worsening renal function and prognosis in pulmonary hypertension patients hospitalized for right heart failure | Q84137797 | ||
| Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America | Q33688646 | ||
| The toxicology of inhaled nitric oxide | Q34116476 | ||
| An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry | Q34249972 | ||
| Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit | Q34313233 | ||
| Comparison of acute hemodynamic effects of inhaled nitric oxide and inhaled epoprostenol in patients with pulmonary hypertension | Q36810842 | ||
| Differences between basal lung levels of select eicosanoids in rat and mouse | Q36810849 | ||
| Association between inhaled nitric oxide treatment and long-term pulmonary function in survivors of acute respiratory distress syndrome | Q36925705 | ||
| Causes and circumstances of death in pulmonary arterial hypertension | Q37186931 | ||
| Medication administration through enteral feeding tubes | Q37340217 | ||
| Inhaled epoprostenol for the treatment of pulmonary arterial hypertension in critically ill adults. | Q37767429 | ||
| Hepatotoxicity by bosentan in a patient with portopulmonary hypertension: a case-report and review of the literature. | Q37859633 | ||
| Intensive care unit management of patients with severe pulmonary hypertension and right heart failure | Q37893845 | ||
| Acquired liver injury in the intensive care unit. | Q38031402 | ||
| Prostacyclin administration errors in pulmonary arterial hypertension patients admitted to hospitals in the United States: a national survey | Q39877981 | ||
| Guidelines for the prevention of central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension | Q42785906 | ||
| Pharmacokinetic and hemodynamic responses to oral sildenafil during invasive testing in children with pulmonary hypertension | Q43111916 | ||
| Infections by gram-negative bacilli in patients with pulmonary arterial hypertension treated with intravenous prostacyclin | Q43531581 | ||
| Impact of hypoxic hepatitis on mortality in the intensive care unit | Q44292857 | ||
| High incidence of bloodstream infection due to gram-negative bacilli in patients with pulmonary hypertension receiving intravenous treprostinil | Q44400993 | ||
| Description and evaluation of a delivery system for aerosolized prostacyclin | Q44532034 | ||
| The end-of-life experience for a cohort of patients with pulmonary arterial hypertension | Q44977581 | ||
| 'Liver function tests' on the intensive care unit: a prospective, observational study | Q45033147 | ||
| Successful treatment of persistent pulmonary hypertension of the newborn with bosentan. | Q45971114 | ||
| The effect of strict blood glucose control on biliary sludge and cholestasis in critically ill patients | Q46051169 | ||
| Oral sildenafil for treatment of severe pulmonary hypertension in an infant | Q46471540 | ||
| Aerosolized iloprost customized for the critically ill. | Q46923236 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | arterial hypertension | Q41861 |
| disease management | Q883708 | ||
| pulmonary hypertension | Q1128595 | ||
| vasodilator agent | Q4008956 | ||
| critical illness | Q65807521 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 523 | |
| P577 | publication date | 2014-10-07 | |
| P1433 | published in | Critical Care | Q5186602 |
| P1476 | title | Management of pulmonary vasodilator therapy in patients with pulmonary arterial hypertension during critical illness | |
| P478 | volume | 18 |
Search more.